Increased apoptosis induction in CD4+CD25+ Foxp3 + T cells contributes to enhanced disease activity in patients with rheumatoid arthritis through IL-10 regulation

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 1, 2014, Pages 78-85

  Li, N ^a   Ma, T ^a   Han, J ^a   Zhou, J ^a   Wang, J ^a   Zhang, J ^a   Zheng, S ^b  

^a First Affiliated Hospital of Fourth Military Medical University   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Apoptosis; Bcl 2; Caspase; Fas; Inter leukin 10; Rheumatoid arthritis; Treg cells

Indexed keywords

C REACTIVE PROTEIN; CASPASE 3; CASPASE 8; CD4 ANTIGEN; FAS ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; PROTEIN BCL 2; RHEUMATOID FACTOR; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; IMMUNOLOGY; MONONUCLEAR CELL; SEVERITY OF ILLNESS INDEX;

ADULT; ANTIGENS, CD95; APOPTOSIS; ARTHRITIS, RHEUMATOID; CASPASE 3; CASPASE 8; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY;

EID: 84896924518     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. ASKENASY N, KAMINITZ A, YARKONI S. Mechanisms of T regulatory cell function. Autoimmun Rev 2008; 7: 370-375.
2. ZHENG SG, WANG J, HORWITZ DA Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J Immunol 2008; 180: 7112-7116.
3. WANG CR, LIU MF Regulation of CCR5 expression and MIP-1alpha production in CD4+ T cells from patients with rheumatoid arthritis. Clin Exp Immunol 2003; 132: 371-378.
4. FURUZAWA-CARBALLEDA J., VARGAS-ROJAS MI, CABRAL AR Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 2007; 6: 169-175.
5. SHAHRARA S, HUANG Q, MANDELIN A.M., POPE RM TH-17 cells in rheumatoid arthritis. Arthritis Res Ther 2008; 10: R93.
6. HORI S, NOMURA T, SAKAGUCHI S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061.
7. FONTENOT JD, GAVIN MA, RUDENSKY AY Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 330-336.
8. SAKAGUCHI S, SAKAGUCHI N, ASANO M., ITOH M, TODA M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
9. HU G, LIU Z, ZHENG C., ZHENG SG Antigen-nonspecific regulation centered on CD25+Foxp3+ Treg cells. Cell Mol Immunol 2010; 7: 414-418.
10. EHRENSTEIN MR, EVANS JG, SINGH A, MOORE S., WARNES G, ISENBERG DA, MAURI C. Compromized function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 2004; 200: 277-285.
11. KRAMMER PH, ARNOLD R, LAVRIK IN Life and death in peripheral T cells. Nat. Rev. Immunol 2007; 7: 532-542.
12. STRASSER A, PELLEGRINI M. T-lymphocyte death during shutdown of an immune response. Trends Immunol 2004; 25: 610-615.
13. BANZ A, PONTOUX C, PAPIERNIK M. Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells. J Immunol 2002; 169: 750-757.
14. FISSON S, DARRASSE-JEZE G, LITVINOVA E., SEPTIER F, KLATZMANN D, LIBLAU R., SALOMON BL. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J Exp Med 2003; 198: 737-746.
15. FRITZSCHING B, OBERLE N, EBERHARDT N., QUICK S, HAAS J, WILDEMANN B., KRAMMER PH, SURI-PAYER E. In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand-but not to TCR-mediated cell death. J Immunol 2005; 175: 32-36.
16. FRITZSCHING B, OBERLE N, PAULY E., GEFFERS R, BUER J, PSCHL J., KRAMMER P, LINDERKAMP O, SURI-PAYER E. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 2006; 108: 3371-3378.
17. RIEDL SJ, SALVESEN GS The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 2007; 8: 405-413.
18. SMITH MD, WALKER JG Apoptosis a relevant therapeutic target in rheumatoid arthritis? Rheumatology (Oxford) 2004; 43: 405-407.
19. MOORE KW, DE WAAL MALEFYT R, COFFMAN RL, O'GARRA A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
20. ANNACKER O, PIMENTA-ARAUJO R, BURLEN-DEFRA-NOUX O, BARBOSA TC, CUMANO A, BANDEIRA A. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol 2001; 166: 3008-3018.
21. HARA M, KINGSLEY CI, NIIMI M, READ S., TURVEY SE, BUSHELL AR, MORRIS PJ, POWRIE F, WOOD KJ IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789-3796.
22. VON HERRATH M.G., HARRISON LC Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 2003; 3: 223-232.
23. HOSAKA N, OYAIZU N, KAPLAN M.H., YAGITA H., PAHWA S. Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from human immunodeficiency virus-infected persons. J Infect Dis 1998; 178: 1030-1039.
24. WANG XZ, ZHANG SJ, CHEN Y.X., CHEN ZX, HUANG YH, ZHANG LJ Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitro. World J Gastroenterol 2004; 10: 2706-2710.
25. BACHIS A, COLANGELO AM, VICINI S, DOE P P, DE BERNARDI MA, BROOKER G, MOCCHETTI I. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 2001; 21: 3104-3112.